Servicio de Endocrinología, Hospital de Pediatría 'Prof. Dr. Juan Pedro Garrahan', Buenos Aires, Argentina.
Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina.
Eur J Endocrinol. 2022 Jul 29;187(3):451-462. doi: 10.1530/EJE-22-0283. Print 2022 Sep 1.
Differences/disorders of sex development (DSD) are congenital conditions in which the development of chromosomal, gonadal, or anatomical sex is atypical.
The aim of this study is to report the histological characteristics and immunoexpression patterns of gonadal parenchyma in patients with 46,XX testicular and ovotesticular DSD, with a focus on the detection of germ cell malignancies.
Inclusion criteria were SRY-negative 46,XX testicular and ovotesticular DSD with available samples from gonadal biopsy or gonadectomy for the review of histological findings. Gonadal histology was assessed on hematoxylin and eosin-stained sections and immunohistochemical analysis. Histopathological criteria from the last World Health Organization classification of urogenital tumors were used to identify undifferentiated gonadal tissue, gonadoblastoma, and dysgerminoma.
Median age at first histological evaluation of gonadal samples was 1.46 years (range: 0.16-16 years). Totally 15 patients were classified as ovotesticular and only 1 as testicular DSD. Most individuals had bilateral ovotestes (12/15). No histological alterations were found in the ovarian parenchyma, while signs of dysgenesis were seen in all cases of testicular parenchyma. In 4/15 ovotesticular DSD, a prepubertal biopsy failed to identify ovarian parenchyma. We detected early prepubertal preinvasive and invasive malignancies in this cohort (five patients had undifferentiated gonadal tissue, five gonadoblastoma, and one dysgerminoma).
46,XX disorders of gonadal development are historically considered at a low risk for germ cell cancer, and the need for assessment of gonadal histology has been questioned. The finding of early germ cell malignancies in our cohort brings awareness and needs further research.
性发育障碍(DSD)是一种先天性疾病,其染色体、性腺或解剖性别发育异常。
本研究旨在报告 SRY 阴性 46,XX 睾丸和卵睾性 DSD 患者的性腺实质组织学特征和免疫表达模式,重点关注生殖细胞恶性肿瘤的检测。
纳入标准为 SRY 阴性 46,XX 睾丸和卵睾性 DSD,有性腺活检或性腺切除术的可用样本,用于评估组织学发现。对苏木精和伊红染色切片进行组织学评估和免疫组织化学分析。使用最新的世界卫生组织泌尿生殖系统肿瘤分类的组织病理学标准来识别未分化性腺组织、卵睾细胞瘤和胚胎瘤。
首次对性腺样本进行组织学评估的中位年龄为 1.46 岁(范围:0.16-16 岁)。总共 15 例患者被归类为卵睾性,仅 1 例为睾丸性 DSD。大多数个体有双侧卵睾(12/15)。卵巢实质未见组织学改变,而睾丸实质均存在发育不良的迹象。在 4/15 例卵睾性 DSD 中,青春期前活检未能识别卵巢实质。在该队列中检测到了早期青春期前的侵袭性恶性肿瘤(五例为未分化性腺组织,五例为卵睾细胞瘤,一例为胚胎瘤)。
46,XX 性腺发育障碍在历史上被认为患生殖细胞癌的风险较低,因此需要评估性腺组织学的必要性一直受到质疑。本研究队列中发现早期生殖细胞恶性肿瘤引起了人们的关注,并需要进一步研究。